Cargando…
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)
BACKGROUND: Apatinib has been proved to be effective and well tolerated among patients in phase II and III studies. Here, we evaluated the safety and effectiveness of apatinib in advanced gastric cancer patients in a real-world setting. METHODS: This study enrolled advanced gastric cancer patients w...
Autores principales: | Wang, Xiang, Zhang, Ruixing, Du, Nan, Yang, Mudan, Zang, Aimin, Liu, Likun, Yu, Junyan, Gao, Jinghua, Zhang, Junping, Fu, Zhanzhao, Ren, Yuchuan, Ma, Liwen, Guo, Jun, Li, Qingshan, Li, Xiaomei, Fan, Zaiwen, Song, Xiang, Liu, Zheng, Zhang, Yan, Li, Guozhong, Yu, Zhonghe, Diao, Jianfeng, Jia, Junmei, Liang, Feng, Wang, Huaqing, Sun, Junzhong, Gao, Yunge, Yang, Ping, Bai, Chunmei, Ren, Xiubao, Zhong, Diansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082876/ https://www.ncbi.nlm.nih.gov/pubmed/32218807 http://dx.doi.org/10.1177/1758835920905424 |
Ejemplares similares
-
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)
por: Wang, Xiang, et al.
Publicado: (2022) -
Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
por: Li, Ningning, et al.
Publicado: (2020) -
Studies of the Efficacy of Low-Dose Apatinib Monotherapy as Third-Line Treatment in Patients with Metastatic Colorectal Cancer and Apatinib’s Novel Anticancer Effect by Inhibiting Tumor-Derived Exosome Secretion
por: Zhao, Lingying, et al.
Publicado: (2022) -
The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Chen, Lei, et al.
Publicado: (2021) -
The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
por: Zhou, Ling, et al.
Publicado: (2023)